Search

everythinglearnresearchcommunity

for

Search:↓

Black cumin and its nanoformulations show promise in treating neurodegenerative diseases.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Shift work disrupts the body's natural clock, leading to health problems.

Metformin improves quality of life, emotional health, and sex life in women with polycystic ovary syndrome.

Lidocaine-loaded microparticles effectively relieve pain and fight bacteria in wounds.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Removing certain brain receptors in mice worsens seizure severity and response to treatment during hormone withdrawal.

Hair loss in women aged 20-30 is often linked to deficiencies in Vitamin D, zinc, ferritin, and haemoglobin, as well as low SHBG levels in those with irregular periods.

Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.

Good communication helps predict successful aging in older Indonesians.

Cannabidiol shows promise as an effective treatment for acne.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Hirsutism can lower a woman's quality of life, causing emotional distress and affecting social and work opportunities.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

Some alternative treatments may help with hair loss, but more evidence is needed to confirm their effectiveness.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Male pattern baldness in medical students is linked to higher depression, loneliness, and internet addiction.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Impulsiveness is common across various psychiatric disorders and linked to many psychological symptoms.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

Post-bariatric surgery patients often face gastrointestinal issues, fatigue, dry skin, hair loss, and anxiety.

Women with skin conditions who have body image concerns often experience mental health issues and a lower quality of life.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

The document concludes that hair loss is influenced by genetics and other factors, and while treatments like finasteride can help, they have limitations and side effects.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.